Mednax Inc Stock
Mednax Inc Stock
We can see a decrease in the price for Mednax Inc. Compared to yesterday it has lost -€0.300 (-1.750%).
Currently there is a rather positive sentiment for Mednax Inc with 3 Buy predictions and 0 Sell predictions.
With a target price of 17 € there is a slightly positive potential of 1.19% for Mednax Inc compared to the current price of 16.8 €.
Our community identified positive and negative aspects for Mednax Inc stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Mednax Inc stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Mednax Inc in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Mednax Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Mednax Inc | -1.750% | 3.012% | -2.286% | 27.612% | -7.065% | 28.571% | -26.293% |
| Select Medical Holdings | 1.460% | 1.460% | 6.923% | -14.198% | 11.200% | -40.598% | -51.056% |
| Chemed Corp. | 0.000% | -4.972% | -9.474% | -36.296% | -5.495% | - | - |
| Davita Inc. | -1.260% | -0.305% | 11.524% | -6.812% | 35.473% | 86.085% | 45.441% |
Comments
Pediatrix Medical Group (NYSE:MD) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Show more
Ratings data for MD provided by MarketBeat
Pediatrix Medical Group, Inc. (NYSE: MD) was upgraded by analysts at Zacks Research to a "strong-buy" rating.
Show more
Ratings data for MD provided by MarketBeat
Pediatrix Medical Group, Inc. (NYSE: MD) had its price target raised by analysts at Macquarie from $19.00 to $20.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for MD provided by MarketBeat